Last checked at 12 Aug 2020 09:09
UK BROKER RATINGS SUMMARY: Davy Cuts IAG To Neutral From Outperform
UK BROKER RATINGS SUMMARY: Davy Cuts IAG To Neutral From Outperform
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News2
GSK Share
Chat2
GSK Share
Trades2,074
GSK
Live RNS1
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,655.00
Bid:
1,654.50
Ask:
1,655.50
Change:
4.00 (0.24%)
Spread:
1.00 (0.06%)
Open:
1,656.50
High:
1,661.50
Low:
1,650.00
Prev. Close:
1,651.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.10 Aug 2020 10:12
Ideagen Trades In Line With Forecasts; Buys Qualsys For GBP16 Million
Ideagen Trades In Line With Forecasts; Buys Qualsys For GBP16 Million
Read more6 Aug 2020 16:05
6 Aug 2020 15:23
Goldman Sachs thinks markets underpricing odds for Covid-19 vaccine before year end
(Sharecast News) - Goldman Sachs thinks the world will be in a very different place in three months' time on at least three front, so much so that investors' expectations for the outcomes will likely set the tone for trading until then.
Read more6 Aug 2020 08:02
GSK receives FDA approval for blood cancer drug
(Sharecast News) - Pharmaceutical giant GlaxoSmithKline has received approval from the US Food and Drug Administration for the use of belantamab mafodotin-blmf (BLENREP) in the treatment of patients with relapsed or refractory multiple myeloma.
Read more6 Aug 2020 05:42
TOP NEWS: US Regulator Approves Glaxo's Blenrep As Myeloma Treatment
TOP NEWS: US Regulator Approves Glaxo's Blenrep As Myeloma Treatment
Read more3 Aug 2020 13:01
WHO warns 'silver bullet' for Covid-19 may never come
(Sharecast News) - The World Health Organization warned on Monday that there is a possibility that a "silver bullet" to combat Covid-19 may never come despite the existing strong hopes for a vaccine.
Read more3 Aug 2020 11:26
Sanofi under investigation on charges including manslaughter
(Sharecast News) - Healthcare company Sanofi Aventis France said on Monday that it had been placed under investigation for charges, including manslaughter.
Read more3 Aug 2020 10:24
UK signs deal with Wockhardt to boost vaccine manufacturing process
LONDON, Aug 3 (Reuters) - Britain said on Monday it had partnered with Indian drugmaker Wockhardt to boost COVID-19 vaccine manufacturing and hopes the firm's could start work as soon as next month.The agreement would see Wockhardt carry out the ‘...
Read more3 Aug 2020 07:50
LONDON MARKET PRE-OPEN: Glaxo And Sanofi Set To Supply Vaccine For EU
LONDON MARKET PRE-OPEN: Glaxo And Sanofi Set To Supply Vaccine For EU
Read more3 Aug 2020 07:43
GSK and Sanofi in talks to supply 300m vaccine doses to EU
(Sharecast News) - GlaxoSmithKline and Sanofi said they were in advanced talks with the European Commission to supply up to 300m doses of a Covid-19 vaccine
Read more31 Jul 2020 21:58
UPDATE 1-U.S. to pay $2.1 bln to Sanofi, GSK, in COVID-19 vaccine deal
(Adds company confirmation of supply talks with EU)By Michael Erman and Carl O'DonnellJuly 31 (Reuters) - The U.S. government will pay $2.1 billion to Sanofi SA and GlaxoSmithKline Plc for COVID-19 vaccines to cover 50 million people and to underwr...
Read more31 Jul 2020 20:51
REFILE-Sanofi, Glaxo advance talks to supply up to 300 mln COVID-19 vaccine doses to Europe -companies
(Refiles to correct typographical error in headline to "doses" instead of "does")July 31 (Reuters) - Sanofi SA and GlaxoSmithKline Plc on Friday said they are in advanced discussions with the European Commission to supply up to 300 million doses o...
Read more31 Jul 2020 20:51
Sanofi, Glaxo advance talks to supply up to 300 mln COVID-19 vaccine does to Europe -companies
July 31 (Reuters) - Sanofi SA and GlaxoSmithKline Plc on Friday said they are in advanced discussions with the European Commission to supply up to 300 million doses of the drugmakers's experimental COVID-19 vaccine.The doses would be manufactured...
Read more31 Jul 2020 17:19
EU wraps up Sanofi talks aimed at securing coronavirus vaccine
BRUSSELS, July 31 (Reuters) - The European Union's executive on Friday wrapped up talks with French drugmaker Sanofi aimed at securing its COVID-19 vaccine for the 27-country EU bloc."The envisaged contract with Sanofi would provide for an option...
Read more